\
&
Contact us
\
&
Contact us
Starts in 2 months from now
LocationNekkerhal Mechelen
This first edition of the DIF-event is organised by the Department of Work, Economy, Science, Innovation and Social Economy in cooperation with VLAIO and Flanders Technology & Innovation (FTI) under the umbrella of the Flemish Innovation and Industry Strategy for Security and Defence (VISD).
It is designed to look at recent developments and future perspectives in defence innovation. The programme also aims to create opportunities for discussion and exchange with key people working at the intersection of technology, innovation and defence.
Defence Innovation in Flanders Day is being set up as a meeting point for people interested in defence innovation in Flanders. It is intended to cover recent developments in the field and to look ahead at future perspectives, while also giving participants space to exchange views and experiences with relevant stakeholders.
A formal invitation with more information on the programme and practical arrangements is expected to follow later.
Interested participants can save the date and contact VISD at visd@vlaanderen.be for interim questions.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
